Spero Therapeutics, Inc. (SPRO)

2.30 -0.10 (-4.17%) USD  |  NASDAQ  |  Feb 20, 16:00
2.38 +0.08 (+3.48%) Pre-Market: 08:51
More

Spero Therapeutics Underperform Recommendations

Underperform Recommendations Chart

View Underperform Recommendations for SPRO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Underperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Underperform Recommendations Range, Past 5 Years

View Underperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Underperform Recommendations Benchmarks

View Underperform Recommendations Benchmarks
Start Trial
BioMarin Pharmaceutical, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
Cassava Sciences, Inc. Upgrade
Alpha Teknova, Inc. Upgrade
Pyxis Oncology, Inc. Upgrade